New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...

A study suggests that patients with wet AMD may regain vision through a novel approach — removing abnormal blood vessels and ...

Telomir Pharmaceuticals shared results from its recent preclinical studies conducted in human retinal cell lines and plans ...

Although AI shows significant promise in diagnosing and managing age-related macular degeneration, its efficacy is reduced by bias, data quality and limited generalizability, according to a review ...

The cause of age-related macular degeneration can be varied and symptoms are often not recognized immediately, according to ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

Baseline angiographic lesion characteristics predictive of clinical responsePublished in peer-reviewed journal Ophthalmic Surgery, Lasers and ...

Optical Coherence Tomography (OCT) provides detailed images of the back of your eye without causing any discomfort. The ...

Retinal Biologics MarketThe Retinal Biologics Market generated USD 19.96 billion in revenue in 2021 and is projected to grow to USD 41.92 billion by 2028, expanding at a CAGR of 11.1% from 2022 to ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...

Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population.